Your guide to AAPS 2011 keynote and plenary speakers

The annual AAPS gathering kicks off this Saturday in Washington, DC. Show attendees are hoping to get answers to the question, "What's coming in the next 25 years?" Here's a guide to the high-profile keynote and plenary speakers who will be addressing attendees this coming week.

Sunday, October 23: Janet Woodcock (pictured), director of the Center for Drug Evaluation and Research at the FDA, will be sharing her thoughts on the agency's regulatory direction in the coming years. He speech begins at 4:30 PM.

Monday, October 24: Outspoken Eli Lilly CEO John Lechleiter (photo) will share his perspective on how the pharmacutical industry needs to respond to the pressures it faces. To get a peek at Lechleiter's previous comments on this topic, click here. NIH head Francis Collins will provide the early development perspective on cutting-edge research that could result in new therapies in the coming years. Finally, Sir Michael Rawlins, chairman of the U.K.'s National Institute of Health & Clinical Excellence, will share his thoughts on how society can weigh the benefits of new treatments against the high prices they often demand. Lechleiter, Collins and Rawlins will all speak at a plenary session starting at 10:00 AM.

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.